施嘉莉祖安遜告迪士尼安排電影於戲院及串流平臺同時上映
Marvel超級英雄片《黑寡婦》(Black Widow)女主角史嘉麗祖安遜(Scarlett Johansson)起訴迪士尼(DIS.US),指控迪士尼安排《黑寡婦》在串流影視平臺Diseny+上播放是違反合約。
迪士尼表示,訴訟沒有任何根據,亦符合與她簽訂的合約,《黑寡婦》在Diseny+上播放亦令史嘉麗祖安遜額外多收2,000萬美元分紅。
根據訴訟,史嘉麗祖安遜認爲迪士尼安排《黑寡婦》同時在戲院及Diseny +上映,會影響戲院入場人數,造成她從票房分紅的收入減少;認爲迪士尼這個舉動是要保住收入之餘,亦希望增加Disney+的付費用戶收入,從而刺激股價表現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.